Intro: why so many women are still on the fence about HRT

If you’re feeling unsure about hormone therapy, you’re not alone. Many women have heard scary, oversimplified headlines about “hormones”—often without the nuance of which hormone, which dose, which route, which patient, and when it was started. Add in conflicting advice online, a rushed medical visit, and the very real fear of “doing the wrong thing,” and it makes sense that so many women pause.

But here’s the part that often gets missed: for many women, the question isn’t just “Should I ever use estrogen?” It’s “When is the right time for me?” Because in menopause medicine, timing can change the risk–benefit picture.

Why timing matters (new conference-presented research)

New research presented at The Menopause Society’s 2025 Annual Meeting suggests the timing of estrogen initiation may be linked to different long-term outcomes.

In a large retrospective cohort analysis using TriNetX electronic health record data, researchers compared groups based on estrogen therapy timing and found:

• Perimenopausal women who used estrogen therapy for at least 10 years before menopause had approximately 60% lower odds of developing breast cancer, heart attack, and stroke compared with other groups.
• Women who began estrogen therapy after menopause had slightly lower odds of breast cancer and heart attack than non-users, but their likelihood of stroke was reported as 4.9% higher compared with non-users.

Important context: this was an observational analysis, so it cannot prove cause and effect. But it supports a bigger clinical idea many women care about: waiting until postmenopause may not be the same as supporting the body earlier in the transition.

Yale outcomes: when symptoms are a signal (not just discomfort)

At Yale, women with severe hot flashes and night sweats weren’t just uncomfortable—they were struggling to function: 82% reported trouble remembering and 80% reported sleep disturbance. After six months of estrogen therapy, those numbers fell to 26% and 10%—a change that many women describe not as a small improvement, but as getting their brain and sleep back.

The bigger stakes: what happens when we wait…

And the stakes may be bigger than symptoms alone. A team led by Dr. Philip M. Sarrel modeled what happens when estrogen is avoided during the window when it appears to offer the most benefit, estimating that roughly 50,000 women died over the following decade because estrogen was not used; he later argued that, over time, that number has grown even larger.

He also pointed to reports in women ages 50–59 receiving estrogen-only therapy showing an all-cause mortality decrease of about 32%, with fewer deaths attributed to cardiovascular disease, hip fracture, breast and colon cancer, and dementia—a reminder that for the right patient, at the right time, estradiol can be about restoring quality of life and protecting long-term health.

A note for women who didn’t start earlier

Timing matters—but it doesn’t mean you “missed your chance” if you didn’t start estrogen earlier in the transition. Many women still explore hormone therapy later in life, especially when symptoms are persistent, quality of life is suffering, or other options haven’t been effective. The key is a personalized, carefully monitored decision that weighs your goals and symptom burden against your individual risk factors.

Why would someone consider HRT after 65?

Some menopausal symptoms don’t fade with time—or they return years later. Common reasons women explore HRT later in life include:

• Persistent vasomotor symptoms: Ongoing hot flashes or night sweats that disrupt sleep and quality of life.
• Genitourinary syndrome of menopause (GSM): Vaginal dryness, burning, urinary urgency, or recurrent urinary tract infections. Local (vaginal) estrogen is often especially helpful and carries lower systemic risk.
• Bone health concerns: Increased risk of osteoporosis or fractures, particularly when other treatments are not tolerated or effective.
• Quality of life: For some women, symptoms significantly affect daily functioning, relationships, and emotional well-being.

Take the next step

None of this means estrogen is right for everyone—or that you should start it without a personalized discussion. It does mean that if you’re symptomatic, it’s worth looking at the full picture instead of defaulting to delay.

Key takeaways

If you’re having symptoms and you’re in the perimenopause-to-early-menopause window, it’s worth having a nuanced conversation about whether estrogen is appropriate for you, what form makes sense, and what your personal risks and benefits look like—because in some women, timing may matter as much as the number on the lab report.